Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» terlipressin
terlipressin
Mallinckrodt secures FDA approval — but not without warning
Endpoints
Thu, 09/15/22 - 11:18 pm
Mallinckrodt
FDA
terlipressin
Terlivaz
liver disease
hepatorenal syndrome
Mallinckrodt tries again with kidney drug terlipressin
Pharmaforum
Wed, 06/15/22 - 10:41 am
Mallinckrodt
terlipressin
hepatorenal syndrome
FDA knocks back Mallinckrodt’s kidney drug terlipressin
Pharmaforum
Wed, 02/23/22 - 10:26 am
Mallinckrodt
hepatorenal syndrome
kidney disease
terlipressin
FDA rejects Mallinckrodt's kidney drug over risk-benefit doubts
Fierce Biotech
Mon, 09/14/20 - 10:16 am
Mallinckrodt
terlipressin
progressive kidney failure
kidney failure
FDA
FDA Action Alert: Possible COVID-19 Action and Mallinckrodt’s Terlipressin
BioSpace
Tue, 09/8/20 - 10:56 am
FDA
COVID-19
vaccines
Mallinckrodt
terlipressin
Go or no go? A quiet month ahead for US approval verdicts
EP Vantage
Fri, 08/28/20 - 10:29 am
FDA
Bristol-Myers Squibb
CC-486
AML
Mallinckrodt
terlipressin
Mesoblast
Ryoncil
FDA Panel Votes 8-7 in Favor of Mallinckrodt's HRS-1 Drug
BioSpace
Thu, 07/16/20 - 11:23 pm
Mallinckrodt
FDA
terlipressin
HRS-1
advisory panels
FDA raises questions about Mallinckrodt's HRS-1 drug before advisory hearing
Endpoints
Wed, 07/15/20 - 11:06 am
Mallinckrodt
terlipressin
HRS-1
FDA
Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study
Endpoints
Thu, 08/15/19 - 10:44 am
Mallinckrodt
clinical trials
hepatorenal syndrome
terlipressin